✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Saroja Pharma Industries India Ltd.

SAROJA

Market Cap
₹14 Cr.
P/E
16.39

Saroja Pharma Industries India Ltd.

  • Saroja Pharma Ind
  • Link Pharma Chem
  • Colinz Laboratories
FAQs on Saroja Pharma Industries India Ltd. Shareprice

Saroja Pharma Ind has given lower returns compared to its competitors.
Saroja Pharma Ind has grown at ~-12.79% over the last 1yrs while peers have grown at a median rate of 18.0%

Saroja Pharma Ind is not expensive.
Latest PE of Saroja Pharma Ind is 17.17, while 3 year average PE is 21.5.
Also latest EV/EBITDA of Saroja Pharma Ind is 0 while 3yr average is 6.59.

View FAQ's On Business
Growth Table
  • Saroja Pharma Industries India Ltd.
  • Link Pharma Chem
  • Colinz Laboratories
Balance Sheet
  • Saroja Pharma Industries India Ltd.
  • Link Pharma Chem
  • Colinz Laboratories
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Saroja Pharma Industries India Ltd.
  • Link Pharma Chem
  • Colinz Laboratories
Cash Flow
  • Saroja Pharma Industries India Ltd.
  • Link Pharma Chem
  • Colinz Laboratories
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Saroja Pharma Industries India Ltd.
  • Link Pharma Chem
  • Colinz Laboratories
Quarterly Results
  • Saroja Pharma Industries India Ltd.
  • Link Pharma Chem
  • Colinz Laboratories
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Saroja Pharma Industries India Ltd. Financials

Balance sheet of Saroja Pharma Ind is strong.
It shouldn't have solvency or liquidity issues.

Yes, The debt of Saroja Pharma Ind is increasing.
Latest debt of Saroja Pharma Ind is ₹7.41 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹5.14 Crs.

No, profit is decreasing.
The profit of Saroja Pharma Ind is ₹0.71 Crs for TTM, ₹0.88 Crs for Mar 2024 and ₹1.06 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Saroja Pharma Ind latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Capital Work in Progress, Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech